Two recent reports by the Health Care Cost Institute appear to use an oversimplified analytic approach and draw overly broad conclusions about price variation and price growth variation, writes Aaron Wesolowski, AHA’s vice president for policy research, analytics and strategy. He says their analysis does not address many of the key factors that can contribute to price variation and growth, while ignoring broader trends in the health care market. Read more

Related News Articles

Blog
In two recent reports, the Health Care Cost Institute (HCCI) appears to use an oversimplified analytic approach and draws overly broad conclusions about price…
Headline
The Food and Drug Administration this week released final guidance for pharmacies, federal facilities and outsourcing facilities that compound or repackage…
Headline
The Drug Enforcement Administration last week published an interim final rule expanding access to medication-assisted treatment under the SUPPORT for Patients…
Headline
The Senate Committee on Appropriations today released all 12 of its fiscal year 2021 funding measures, including the appropriations bill for the departments of…
Headline
Hundreds of hospital and health system leaders today urged senators and representatives to support key priorities, including additional COVID-19 relief, during…
Headline
AHA will provide live coverage and analysis of the Nov. 10 U.S. Supreme Court oral arguments in the latest challenge of the Affordable Care Act. AHA outside…